Concepedia

Pilar Goya

PG

Statistics

Publications

67

Citations

1.6K

H-Index

22

Active since

1978

Affiliations

Instituto de Química Médica(Current)

Consejo Superior de Investigaciones Científicas

Universidad Complutense de Madrid

Universidad Rey Juan Carlos

Biomedical Research Networking Center on Neurodegenerative Diseases

Pilar Goya is an author at Instituto de Química Médica specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1978–2016

67

Publications

67

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21

Francisco Javier Pavón, Ainhoa Bilbao, Laura Hernández‐Folgado et al. · Neuropharmacology · 2006 · 113 citations

, , +5

Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study

Cristina Montero, Nuria E. Campillo, Pilar Goya et al. · European Journal of Medicinal Chemistry · 2004 · 97 citations

, , +14

New aromatic iminoimidazolidine derivatives as α1-adrenoceptor antagonists: a novel synthetic approach and pharmacological activity

Christophe Dardonville, Pilar Goya, Isabel Rozas et al. · Bioorganic & Medicinal Chemistry · 2000 · 65 citations

, , +8

Discovery of 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1<i>H</i>-1,2,4-triazole, a Novel in Vivo Cannabinoid Antagonist Containing a 1,2,4-Triazole Motif

Nadine Jagerovic, Laura Hernández‐Folgado, Ibón Alkorta et al. · Journal of Medicinal Chemistry · 2004 · 65 citations · Full text

, , +15

Anti‐obesity efficacy of LH‐21, a cannabinoid CB<sub>1</sub> receptor antagonist with poor brain penetration, in diet‐induced obese rats

Mónica Alonso, Antonia Serrano, Margarita Vida et al. · British Journal of Pharmacology · 2011 · 57 citations · Full text

, , +13

1–5 of 67